【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-011594 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-11-12,Director,Shook Bruce Joseph ,卖出,7797普通股, $5.30
$Neuronetics(STIM)$ 内部交易: 2021-11-12,Director,Shook Bruce Joseph ,期权,7797普通股, $4.06
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-010979 Size: 7 KB 网页链接
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-015312 Act: 34 Size: 9 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-21-015160 Act: 34 Size: 149 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-015163 Act: 34 Size: 531 KB 网页链接
$Neuronetics(STIM)$ 8-K/A [Amend] Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-013300 Act: 34 Size: 186 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-013134 Act: 34 Size: 172 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-21-009265 Size: 4 KB 网页链接